2 Result: Abcam
Breaking: Abcam to be Acquired by Danaher; Setback for NovoCure
August 28th, 2023
Abcam plc (Nasdaq: ABCM) has agreed to be acquired by Danaher Corporation (NYSE: DHR) for $24.00 per share in cash. The transaction has received unanimous approval from both Abcam's and Danaher's Boards of Directors. In pre-market, $ABCM is tra. Read more
Lucintel Forecasts Epigenetic Market to grow at a CAGR of 14% from 2019 to 2024
December 08th, 2021
Dallas, TX / CRWE PRESS RELEASE / Dec. 9, 2021 - According to the recent study the Epigenetic Market is projected to grow at a CAGR of 14% from 2019 to 2024. Growth in this market is primarily driven by declining sequencing costs and time, incre. Read more
Want To Find Some News?
News By Industries
Recent Post
-
FTC Takes Action to Prevent Anticompetitive Arrangement in Beretta, Ruger Deal
September 16th, 2026Why Opponent Preparation Matters for Post-Graduate Athletes
September 16th, 2026The Work Behind the Game: How Football Teams Prepare to Compete
September 15th, 2026NJCP Operates on a Prep Model Built Around a Full Season
September 14th, 2026Earnings Preview: High Tide, Kestra Medical, and RF Industries in Focus
September 12th, 2026
Member Login